Palisade Bio Inc (PALI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -20,904 | -16,139 | -10,501 | -5,053 | -22,629 |
| Depreciation Amortization | 1,216 | 911 | 601 | 299 | 1,178 |
| Accounts receivable | 188 | 206 | 207 | 217 | -216 |
| Other Working Capital | -2,195 | -1,925 | -940 | -656 | 1,534 |
| Other Operating Activity | 2,763 | 1,915 | 1,109 | 472 | 8,425 |
| Operating Cash Flow | $-18,932 | $-15,032 | $-9,524 | $-4,720 | $-11,707 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 7,490 | 9,990 | -25 | -25 | -15,008 |
| PPE Investments | -176 | -128 | -96 | -16 | -208 |
| Purchase Sale Intangibles | N/A | N/A | -70 | N/A | N/A |
| Other Investing Activity | -67 | -61 | -70 | -57 | -348 |
| Investing Cash Flow | $7,246 | $9,800 | $-191 | $-98 | $-15,564 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 4,213 |
| Debt Repayment | -1,154 | N/A | N/A | N/A | -1,929 |
| Common Stock Issued | 6,006 | 6,006 | 6,006 | 6,006 | 21,263 |
| Other Financing Activity | -964 | -160 | -160 | -113 | -602 |
| Financing Cash Flow | $3,887 | $5,846 | $5,846 | $5,893 | $22,944 |
| Exchange Rate Effect | -4 | -2 | 0 | 0 | -1 |
| Beginning Cash Position | 12,519 | 12,519 | 12,519 | 12,519 | 16,846 |
| End Cash Position | 4,717 | 13,131 | 8,649 | 13,594 | 12,519 |
| Net Cash Flow | $-7,802 | $612 | $-3,870 | $1,075 | $-4,327 |
| Free Cash Flow | |||||
| Operating Cash Flow | -18,932 | -15,032 | -9,524 | -4,720 | -11,707 |
| Capital Expenditure | -176 | -128 | -96 | -16 | -208 |
| Free Cash Flow | -19,108 | -15,161 | -9,620 | -4,736 | -11,915 |